A systematic review of CQ-resistant Plasmodium vivax malaria infections in India

References

• Mahgoub H, Gasim GI, Musa IR, et al. Severe Plasmodium vivax malaria among sudanese children at New Halfa Hospital, Eastern Sudan. Parasites Vectors. 2012;5(1):154. doi: 10.1186/1756-3305-5-154
   PubMed Web of Science ®Google Scholar
• World malaria report. 2021 [Internet]. [cited 2023 Jan 27]. Available from: https://www.who.int/publications-detail-redirect/9789240040496
   Google Scholar
• Price RN, von Seidlein L, Valecha N, et al. Global extent of CQ-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014 Sep 8;14(10):982–991. doi: 10.1016/S1473-3099(14)70855-2
   PubMed Web of Science ®Google Scholar
• Rieckmann KH, Davis DR, Hutton DC. PLASMODIUM VIVAX RESISTANCE to CQ? Lancet. 1989 Nov 18;334(8673):1183–1184. doi: 10.1016/S0140-6736(89)91792-3
   Google Scholar
• Baird JK, Basri H, Purnomo BM, et al. Resistance to CQ by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1991 May 1;44(5):547–552. doi: 10.4269/ajtmh.1991.44.547
   PubMed Web of Science ®Google Scholar
• Garg M, Gopinathan N, Bodhe P, et al. Vivax malaria resistant to CQ: case reports from Bombay. Trans R Soc Trop Med Hyg. 1995 Nov 1;89(6):656–657. doi: 10.1016/0035-9203(95)90432-8
   PubMed Web of Science ®Google Scholar
• Price RN, Auburn S, Marfurt J, et al. Phenotypic and genotypic characterization of drug-resistant Plasmodium vivax. Trends Parasitol. 2012 Nov;28(11):522–529. doi: 10.1016/j.pt.2012.08.005
   PubMed Web of Science ®Google Scholar
• World Health Organization. Control and elimination of Plasmodium vivax malaria: a technical brief [Internet]. World Health Org. 2015. https://www.who.int/publications-detail-redirect/9789241509244
   Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan — a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4
   PubMedGoogle Scholar
• World Health Organization. Methods for surveillance of antimalarial drug efficacy. World Heal Organisation. 2009;85 https://www.who.int/docs/default-source/documents/publications/gmp/methods-for-surveillance-of-antimalarial-drug-efficacy.pdf?sfvrsn=29076702_2.
   Google Scholar
• Singh RK. Emergence of CQ-resistant vivax malaria in south Bihar (India). Trans R Soc Trop Med Hyg. 2000;94(3):327. doi: 10.1016/S0035-9203(00)90344-4
   PubMed Web of Science ®Google Scholar
• Nandy A, Addy M, Maji AK, et al. Monitoring the CQ sensitivity of Plasmodium vivax from Calcutta and Orissa, India. Ann Trop Med Parasitol. 2003 Apr;97(3):215–220. doi: 10.1179/000349803235001868
   PubMed Web of Science ®Google Scholar
• Bruce-Chwatt LJ, Black RH, Canfield CJ, et al. Chemotherapy of malaria. 2nd ed. Geneva: World Health Organization; 1986.
   Google Scholar
• Srivastava HC, Yadav RS, Joshi H, et al. Therapeutic responses of Plasmodium vivax and P. falciparum to CQ, in an area of western India where P. vivax predominates. Ann Trop Med Parasitol. 2008 Sep;102(6):471–480. doi: 10.1179/136485908X311759
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2002). Monitoring antimalarial drug resistance. Report of a WHO consultation. Geneva, Switzerland 3B5 December 2001. Document WHO/CDS/RBM/2002.39. Geneva: WHO.
   Google Scholar
• World Health Organization. (2003). Assessment and Monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Document WHO/HTM/RBM/2003.50. Geneva: WHO.
   Google Scholar
• Valecha N, Joshi H, Eapen A, et al. Therapeutic efficacy of CQ in Plasmodium vivax from areas with different epidemiological patterns in India and their pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg. 2006 Sep 1;100(9):831–837. doi: 10.1016/j.trstmh.2005.11.012
   PubMed Web of Science ®Google Scholar
• Mishra N, Singh JPN, Srivastava B, et al. Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009–2010. Bull World Health Organ. 2012 Dec 1;90(12):895–904. doi: 10.2471/BLT.12.109124
   PubMed Web of Science ®Google Scholar
• Ganguly S, Saha P, Guha SK, et al. In vivo therapeutic efficacy of CQ alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother. 2013 Mar;57(3):1246–1251. doi: 10.1128/AAC.02050-12
   PubMed Web of Science ®Google Scholar
• Shalini S, Chaudhuri S, Sutton PL, et al. CQ efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India. Malar J. 2014 Mar 31;13(1):129. doi: 10.1186/1475-2875-13-129
   PubMedGoogle Scholar
• Rishikesh K, Kamath A, Hande MH, et al. Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. Malar J. 2015 Aug 11;14(1):310. doi: 10.1186/s12936-015-0824-y
   PubMedGoogle Scholar
• Valecha N, Savargaonkar D, Srivastava B, et al. Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with CQ in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study. Malar J. 2016 Jan 27;15(1):42. doi: 10.1186/s12936-016-1084-1
   PubMedGoogle Scholar
• Saravu K, Kumar R, Ashok H, et al. Therapeutic assessment of CQ-Primaquine combined regimen in adult cohort of Plasmodium vivax malaria from primary care centres in Southwestern India. PLoS One. 2016 Jun 17;11(6):e0157666. doi: 10.1371/journal.pone.0157666
   PubMed Web of Science ®Google Scholar
• Singh G, Singh R, Urhehar AD. Simple molecular methods for early detection of CQ drug resistance in Plasmodium vivax and Plasmodium falciparum. J Clin Diagn Res JCDR. 2016 Jul;10(7):DC19–23. doi: 10.7860/JCDR/2016/18596.8154
   Google Scholar
• Matlani M, Kumar A, Singh V. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India. Exp Parasitol. 2021 Jan 1;220:108047. doi: 10.1016/j.exppara.2020.108047
   PubMed Web of Science ®Google Scholar
• Munn Z, Moola S, Lisy K, et al. Chapter 5: systematic reviews of prevalence and incidence. In: Aromataris E, and Munn Z, editors. JBI manual for evidence synthesis. JBI; 2020 doi:10.46658/JBIMES-20-06.
   Google Scholar
• Ferreira MU, Nobrega de Sousa T, Rangel GW, et al. Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions. Int J Parasitol Drugs Drug Resist. 2021 Apr;15:9–24. Epub 2020 Dec 5. PMID: 33360105; PMCID: PMC7770540. doi: 10.1016/j.ijpddr.2020.12.001.
   PubMed Web of Science ®Google Scholar
• Kulkarni AV, Kasturi L, Amin A, et al. Therapy and drug resistance in malaria. Indian J Pediatr. 2000 Jan;67(1):33–35. doi: 10.1007/BF02802634
   PubMedGoogle Scholar
• Dua VK, Kar PK, Sharma VP. CQ resistant Plasmodium vivax malaria in India. Trop Med Int Health. 1996;1(6):816–819. doi: 10.1111/j.1365-3156.1996.tb00116.x
   PubMed Web of Science ®Google Scholar
• Kshirsagar NA, Gogtay NJ, Rajgor D, et al. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India. Ann Trop Med Parasitol. 2000 Mar;94(2):189–190. doi: 10.1080/00034983.2000.11813528
   PubMed Web of Science ®Google Scholar
• Virdi VS, Goraya JS, Khadwal A, et al. Neonatal transfusion malaria requiring exchange transfusion. Ann Trop Paediatr. 2003 Sep;23(3):205–207. doi: 10.1179/027249303322296529
   PubMed Web of Science ®Google Scholar
• Shah I. CQ resistant vivax malaria in an infant: a report from India. J Vector Borne Dis. [2008 Jun 1];45(2):176.
   PubMedGoogle Scholar
• Mohan K, Maithani MM. Congenital malaria due to CQ-resistant Plasmodium vivax: a case report. J Trop Pediatrics. 2010 Dec 1;56(6):454–455. doi: 10.1093/tropej/fmq025
   PubMed Web of Science ®Google Scholar
• Pukrittayakamee S, Imwong M, Looareesuwan S, et al. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop. 2004 Feb;89(3):351–356. PMID: 14744561. doi: 10.1016/j.actatropica.2003.10.012
   PubMed Web of Science ®Google Scholar
• Kevin Baird J, Hoffman SL. Primaquine therapy for malaria. Clinl Infect Dis. 1 November 2004;39(9):1336–1345. doi: 10.1086/424663
   PubMed Web of Science ®Google Scholar
• Baird JK, Leksana B, Masbar S, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg. 1997 Jun;56(6):621–626. doi: 10.4269/ajtmh.1997.56.621. PMID: 9230792
   PubMed Web of Science ®Google Scholar
• National Framework for Malaria Elimination (2016–2030). Delhi: National Vector Borne Disease Control Programme 2016. Available from: http://www.indiaenvironmentportal.org.in/files/file/National-framework-for-malaria-elimination-in-India-2016–2030.pdf.
   Google Scholar